Moderna CEO Bancel says personalized mRNA cancer vaccine with Merck will work in a variety of tumors

Moderna CEO Stephane Bancel said he believes the personalized mRNA cancer vaccine Moderna is developing with Merck & Co. will work in a variety of tumors, addressing a key question about the company's future.

Detected & updated continuously · Source: Nebula